Quality of Life in People with HIV at the End of Life: Preliminary Results from the Last Gift Observational Cohort Study.

IF 2.9 3区 医学 Q3 IMMUNOLOGY JAIDS Journal of Acquired Immune Deficiency Syndromes Pub Date : 2024-10-03 DOI:10.1097/QAI.0000000000003536
Brahm Coler, Gordon Honerkamp Smith, Anish K Arora, Adam Wells, Stephanie Solso, Cheryl Dullano, Susanna Concha-Garcia, Eddie Hill, Patricia K Riggs, Anastasia Korolkova, Robert Deiss, Davey Smith, Erin E Sundermann, Sara Gianella, Antoine Chaillon, Karine Dubé
{"title":"Quality of Life in People with HIV at the End of Life: Preliminary Results from the Last Gift Observational Cohort Study.","authors":"Brahm Coler, Gordon Honerkamp Smith, Anish K Arora, Adam Wells, Stephanie Solso, Cheryl Dullano, Susanna Concha-Garcia, Eddie Hill, Patricia K Riggs, Anastasia Korolkova, Robert Deiss, Davey Smith, Erin E Sundermann, Sara Gianella, Antoine Chaillon, Karine Dubé","doi":"10.1097/QAI.0000000000003536","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>As people living with HIV (PWH) age, they face new challenges that can have a negative impact on their quality of life (QOL) and mental health.</p><p><strong>Setting: </strong>This study enrolled PWH at the end of life (EOL) who were actively engaged in cure-related research in Southern California, United States. EOL was defined as having a prognosis of six months or less to live. We examined the relationship between QOL, mental health, and research participation.</p><p><strong>Methods: </strong>Structured assessments were used to collect comprehensive data on QOL and mental health.</p><p><strong>Results: </strong>From 2017 to 2023, 35 PWH in their final stages of life who were actively engaged in cure-related research were enrolled. Their median age was 62.7 years, and most were White or otherwise non-Hispanic/non-Latino (90.6%), and male (86.7%). Changes in QOL and the presence of neurologic and psychiatric conditions, with a focus on depression and anxiety, were the primary outcomes assessed in this study. Participants had stable QOL scores throughout the study. There was an inverse relationship between QOL and BDI scores, with higher mean QOL scores being associated with lower mean BDI scores (p < 0.001).</p><p><strong>Conclusion: </strong>QOL remained stable among PWH who participate in cure-related research at EOL. The inverse relationship between QOL and depressive symptoms suggests that participation in cure-related research may improve QOL or reduce depressive symptoms in this population. Future interventions should look into ways to improve the well-being of PWH at EOL through research and customized mental health interventions.</p>","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003536","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: As people living with HIV (PWH) age, they face new challenges that can have a negative impact on their quality of life (QOL) and mental health.

Setting: This study enrolled PWH at the end of life (EOL) who were actively engaged in cure-related research in Southern California, United States. EOL was defined as having a prognosis of six months or less to live. We examined the relationship between QOL, mental health, and research participation.

Methods: Structured assessments were used to collect comprehensive data on QOL and mental health.

Results: From 2017 to 2023, 35 PWH in their final stages of life who were actively engaged in cure-related research were enrolled. Their median age was 62.7 years, and most were White or otherwise non-Hispanic/non-Latino (90.6%), and male (86.7%). Changes in QOL and the presence of neurologic and psychiatric conditions, with a focus on depression and anxiety, were the primary outcomes assessed in this study. Participants had stable QOL scores throughout the study. There was an inverse relationship between QOL and BDI scores, with higher mean QOL scores being associated with lower mean BDI scores (p < 0.001).

Conclusion: QOL remained stable among PWH who participate in cure-related research at EOL. The inverse relationship between QOL and depressive symptoms suggests that participation in cure-related research may improve QOL or reduce depressive symptoms in this population. Future interventions should look into ways to improve the well-being of PWH at EOL through research and customized mental health interventions.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
生命末期艾滋病病毒感染者的生活质量:最后的礼物》观察性队列研究的初步结果。
背景:随着艾滋病病毒感染者(PWH)年龄的增长,他们面临着新的挑战,这些挑战可能会对他们的生活质量(QOL)和心理健康产生负面影响:本研究招募了美国南加州积极参与治愈相关研究、处于生命末期(EOL)的艾滋病病毒感染者。生命末期被定义为预后可存活六个月或更短时间。我们研究了 QOL、心理健康和参与研究之间的关系:方法:采用结构化评估收集有关 QOL 和心理健康的综合数据:从 2017 年到 2023 年,有 35 名处于生命最后阶段、积极参与治愈相关研究的残疾人参加了研究。他们的中位年龄为 62.7 岁,大多数为白人或其他非西班牙裔/非拉丁裔(90.6%),男性(86.7%)。本研究评估的主要结果是 QOL 的变化以及是否存在神经和精神疾病,重点是抑郁和焦虑。在整个研究过程中,参与者的 QOL 分数保持稳定。QOL与BDI得分之间存在反比关系,QOL平均得分越高,BDI平均得分越低(p < 0.001):结论:参与治愈相关研究的 PWH 在临终前的 QOL 保持稳定。QOL与抑郁症状之间的反比关系表明,参与治愈相关研究可改善该人群的QOL或减轻抑郁症状。未来的干预措施应研究如何通过研究和定制的心理健康干预措施来改善临终前残疾人的福祉。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.80
自引率
5.60%
发文量
490
审稿时长
3-6 weeks
期刊介绍: JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
期刊最新文献
Tenofovir Disoproxil Fumarate/Emtricitabine Prophylaxis Has No Effect on Bone Mineral Density and Bone Mineral Content in African Breastfeeding Women Receiving Pre-Exposure Prophylaxis for HIV. Using machine learning techniques to predict viral suppression among people with HIV. Non-liver malignancies as main cause of mortality after HCV eradication among people living with HIV. Predictors of Injection Visit Adherence in Those Receiving Injectable Cabotegravir/Rilpivirine. Real-world comparative Analysis of Liposomal Doxorubicin versus Paclitaxel as First-Line Therapy for Kaposi Sarcoma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1